HI
AYTU icon

Harbour Investments’s AYTU BioPharma AYTU Stock Holding History

Harbour Investments’s Portfolio AYTU Stock Details AYTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Hold
0
– – – 3004
2022
Q3 		– Hold
0
– – – 2719
2022
Q2 		– Hold
0
– – – 2719
2021
Q4 		– Hold
0
– – – 2695
2021
Q3 		– Hold
0
– – – 3724
2021
Q2 		– Sell
-3
Closed -$352 – 3759
2021
Q1 		$0 Buy
+3
New +$476 ﹤0.01% 3592

Other funds holding AYTU

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
ACM
Allred Capital Management Dallas, Texas $275M AUM 18.19% 1-Year Est. Return

Harbour Investments's AYTU Position: Q4 2022 in Review

Harbour Investments held its AYTU BioPharma (AYTU) position steady in Q4 2022 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #3004.

Harbour Investments first reported a position in AYTU in Q1 2021 and has held it in 1 quarter since. The position peaked at $0 in Q1 2021. 36 funds tracked by Wall St. Rank hold AYTU as of Q4 2022.

  • Harbour Investments held 0 shares of AYTU BioPharma worth $0 as of Q4 2022.
  • Harbour Investments left its AYTU BioPharma share count unchanged in Q4 2022.
  • AYTU BioPharma made up ﹤0.01% of Harbour Investments's portfolio in Q4 2022, its #3004 holding.
  • Harbour Investments first reported a position in AYTU BioPharma in Q1 2021 and has held it in 1 quarter since.
  • Harbour Investments's AYTU BioPharma position peaked at $0 in Q1 2021.
  • 36 funds tracked by Wall St. Rank held AYTU BioPharma as of Q4 2022.

Based on Harbour Investments's 13F filing for Q4 2022, filed 16 Feb 2023.